文献速递乳腺US乳腺X线

纽约州乳腺密度强制告知:筛查超声随访数据

New York State Breast Density Mandate: Follow-up Data With Screening Sonography.
PubMed 文献 · J Ultrasound Med · 2017-06-28

本研究回顾性分析2013年1月1日至2015年8月31日期间195982例筛查性乳腺X线摄影,其中83234例(42.5%)被告知乳腺组织为不均匀致密或极度致密。对4898例致密乳腺女性行5434次筛查超声,仅超声发现的100个可疑病灶均行组织取样,诊断18例恶性肿瘤(均为浸润性),阳性预测值18.0%,活检率2.0%,癌症检出率3.3/1000。结论认为致密乳腺筛查超声可检出其他方法隐匿的恶性肿瘤且活检率低。

要点

  • 致密乳腺女性筛查超声的癌症检出率为3.3/1000,阳性预测值18.0%。
  • 筛查超声总体活检率为2.0%,仅超声发现的100个BI-RADS 4/5病灶均经组织学诊断。
  • 95.7%的筛查超声结果为BI-RADS 1或2类,BI-RADS 3类病灶101个。

核心结论

  • 致密乳腺筛查超声可检出其他方法隐匿的恶性肿瘤,且活检率低。

研究设计与样本

  • 回顾性病历回顾研究,数据来自2013年1月1日至2015年8月31日单中心(本机构)筛查人群,共195982次筛查性乳腺X线摄影,其中83234例(42.5%)为不均匀致密或极度致密乳腺;对4898例致密乳腺女性行5434次筛查超声,参考标准为组织病理学活检结果。

关键影像表现/征象

  • 95.7%的筛查超声结果为BI-RADS 1或2类。
  • 101个病灶被评为BI-RADS 3类。
  • 134个可疑病灶被评为BI-RADS 4或5类,其中100个仅超声可见,均行组织取样,诊断18例恶性肿瘤,均为浸润性。

诊断标准与关键数值

  • 筛查超声阳性预测值18.0%(对应仅超声发现的100个BI-RADS 4/5病灶中诊断18例恶性)。
  • 总体活检率2.0%。
  • 癌症检出率3.3/1000。

临床应用与阅片要点

  • 对乳腺X线摄影示不均匀致密或极度致密的女性,筛查超声可检出其他方法隐匿的恶性肿瘤。
  • 筛查超声结果多数为BI-RADS 1或2类,仅超声发现的BI-RADS 4/5病灶阳性预测值为18.0%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the impact on breast cancer detection from screening breast sonography performed in women with mammographically dense breasts.

METHODS: This study used a retrospective chart review. Data collected included total number of screening mammograms, total number of dense breast screening sonograms, total number of procedures performed, biopsy results, and demographic data. Data were obtained from January 1, 2013, through August 31, 2015. During this period, there were a total of 195,982 screening mammographic examinations performed at our facility. Of these, 83,234 patients (42.5%) were informed that their breast tissue was heterogeneously dense or extremely dense. We specifically reviewed cases to identify those with findings on sonography only. The positive predictive value, biopsy rate, and cancer detection rate were determined.

RESULTS: During the study period, 5434 screening sonographic examinations were performed in 4898 women with heterogeneously dense or extremely dense breasts. Most (95.7%) of the sonographic examinations resulted in an American College of Radiology Breast Imaging Reporting and Data System (BI-RADS) category 1 or 2 designation. A total of 101 lesions were given a BI-RADS 3 designation; 134 suspicious findings were given a BI-RADS 4 or 5 designation; and 100 of these were seen on sonography only, all of which underwent tissue sampling, resulting in the diagnosis of 18 malignancies; all were invasive. In evaluating screening sonographic findings, we found a positive predictive value of 18.0%, with an overall biopsy rate of 2.0% and a cancer detection rate of 3.3 per 1000.

CONCLUSIONS: The results of our continued evaluation of our screening sonography program confirm that screening breast sonography in women with dense breast tissue can detect otherwise occult malignancy, with a low biopsy rate.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Destounis S, Arieno A, Morgan R, et al. New York State Breast Density Mandate: Follow-up Data With Screening Sonography. J Ultrasound Med. 2017. PMID: 28656638. doi:10.1002/jum.14294

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。